Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Online First
    • Multimedia
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • The Issue in Brief (Plain Language Summaries)
    • Call for Papers
  • Info for
    • Authors
    • Reviewers
    • Media
    • Job Seekers
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • RSS
    • Email Alerts
    • Journal Club
  • Contact
    • Feedback
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Online First
    • Multimedia
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • The Issue in Brief (Plain Language Summaries)
    • Call for Papers
  • Info for
    • Authors
    • Reviewers
    • Media
    • Job Seekers
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • RSS
    • Email Alerts
    • Journal Club
  • Contact
    • Feedback
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Brief

Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes

Heather P. Whitley, Courtney Hanson and Jason M. Parton
The Annals of Family Medicine March 2017, 15 (2) 162-164; DOI: https://doi.org/10.1370/afm.2035
Heather P. Whitley
1Auburn University Harrison School of Pharmacy, Department of Pharmacy Practice Baptist Health System, Montgomery Family Medicine Residency Program, Montgomery, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: whitlhp@auburn.edu
Courtney Hanson
2The University of Alabama, Culverhouse College of Commerce and Business Administration, Department of Information Systems, Statistics and Management Science, Tuscaloosa, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason M. Parton
2The University of Alabama, Culverhouse College of Commerce and Business Administration, Department of Information Systems, Statistics and Management Science, Tuscaloosa, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This prospective longitudinal study compares diabetes screenings between standard practices vs systematically offered point-of-care (POC) hemoglobin A1c (HbA1c) tests in patients aged 45 years or older. Systematically screened participants (n = 164) identified 63% (n = 104) with unknown hyperglycemia and 53% (n = 88) in prediabetes. The standard practice (n = 324) screened 22% (n = 73), most commonly by blood glucose (96%); 8% (n = 6) and 33% (n = 24) were found to have diabetes and prediabetes, respectively. The association between screening outcome and screening method was statistically significant (P = 0.005) in favor of HbA1C. HbA1c may be the most effective method to identify patients unknowingly living in hyperglycemia. Point-of-care tests further facilitate screening evaluation in a timely and feasible fashion.

  • diabetes
  • prediabetes
  • screening
  • hemoglobin A1C; HbA1c

INTRODUCTION

Millions of Americans are unknowingly living with chronic hyperglycemia. Early identification through a reliable and convenient screening test may lead to prompt identification, intervention, and improved health outcomes.1 Fasting blood glucose measured through a chemistry panel is inconvenient, highly variable, and delays care, unlike HbA1c point-of-care (POC) tests. This investigates the population of adults 45 years of age and older for frequency of diabetes screening by standard practices vs a systematically offered HbA1c POC test and determines differences in identifying unknown chronic hyperglycemia in a single-physician family medicine clinic.

METHODS

Patients with scheduled medical appointments on Tuesdays (active screening arm) and Wednesdays (standard practice arm) between April 2013 and March 2014 were evaluated by the clinical pharmacist. Patients’ electronic medical records (EMR) were assessed for eligibility criteria: those aged 45 years or older were included; pregnancy, past medical history of diabetes (type 1 or type 2), HbA1c test in the past 12 months, or steroid use (injectable or oral) in the past 3 months were exclusion criteria. Those meeting EMR criteria in the active screening arm were offered a free POC HbA1c test by the clinical pharmacist during their scheduled medical appointment after verbally confirming eligibility.2 The EMR of eligible “standard practice arm” patients was assessed for diabetes screenings under usual care. Study characteristics were examined with descriptive statistics; proportional differences were evaluated using a Pearson’s χ2 analysis of independence.

RESULTS

The standard practice arm evaluated 709 patients; however, 324 were included in final analysis per exclusion criteria. The active screening arm evaluated 689 patients. Exclusion criteria removed 390, and 117 were unreachable due to logistics; 182 were offered participation, 17 declined, and 164 were screened. (Supplemental Appendix 1, http://www.annfammed.org/content/15/2/162/suppl/DC1.) Demographics were similar between the 2 study arms (Table 1). The majority was Caucasian (87%) and was comprised of more females (55%) than males. Age ranged from 45 to 91 (mean 63) years. They were predominately obese with an average height, weight, and BMI of 1.69 meters, 86.5 kg, and 31.0 kg/m2, respectively.

View this table:
  • View inline
  • View popup
Table 1

Patient Demographics, Screening Practices, and Outcomes

In the active screening arm only 37% (n = 60) of patients had an HbA1c ≤5.6%. Whereas 53% (n = 88) had an HbA1c in the prediabetes range (5.7%–6.4%) and 10% (n = 16) of patients had an HbA1c ≥6.5%. The average HbA1c values for patients with euglycemia, prediabetes, and diabetes were 5.34%, 5.93%, and 6.68%, respectively.

The standard practice arm tested 73 (22%) patients, most commonly via blood glucose (n = 70, 96%). Only 4 individuals were screened by HbA1c test; 1 of whom received both HbA1c and blood glucose. Through this process, 33% (n = 24) were in the prediabetes glycemic range, and 8% (n = 6) tested in the diabetes glycemic range. The majority was euglycemic (n = 43, 59%).

Glycemic outcomes were compared between the active and standard practices arms. The χ2 analysis (Table 2) showed that the glycemic outcomes vs methods (active vs standard) were statistically different from one another (P = 0.005).

View this table:
  • View inline
  • View popup
Table 2

Comparative Analysis of Standard Practice Arm to Active Screening Arm

DISCUSSION

This study demonstrates that systematically screening adults (aged ≥45 years) for diabetes using a POC HbA1c test, vs standard practices, greatly increases the chances for a screen to occur (P = 0.005). Outcomes show that 63% (n = 104) of patients systematically screened were unknowing living in chronic hyperglycemia compared to 41% (n = 30) under standard practices. Interestingly, the most profound impact was in ability to identify prediabetes (53% vs 33% respectively). Under standard practice, blood glucose was the most common screening method used (96%, n = 70), which was often captured as part of a larger venipuncture chemistry panel. The 22% difference in hyperglycemic detectability between screening arms is best explained by test utility.

HbA1c is durable and more accurately reflects sustained hyperglycemia over a 3-month period as compared to fasting or random glucose. Diagnosis by glucose alone may initially be missed until the glycemic curve fully shifts upward, crosses the diagnostic threshold, and bothersome symptoms develop, impacting daily life. Therefore, HbA1c may be a superior screening method,3 due to effectively identifying individuals early on in the course of the disease, which accounts for this study’s difference in identified hyperglycemia. Furthermore, POC HbA1c devices improve patient care by allowing for immediate assessment, patient education, and early management initiated by the practitioner.4–6 Identifying and treating chronic hyperglycemia early can result in clinically meaningful patient outcomes, which is most feasible by HbA1c screenings and further facilitated by POC devices.

The American Diabetes Association recommends screening adults aged ≥45 years or those younger with at least 1 risk factor.1 Conversely, United States Preventative Services Task Force (USPSTF) recommendations focus on overweight or obese patients aged 40 to 70 years.7 Post-hoc analysis applying USPSTF recommendations reduced screenings from 164 to 104 patients, with similar results: average HbA1c 5.78%, 10% HbA1c ≥6.5%, and 50% HbA1c 5.7%–6.4%, but resulted in a higher average HbA1c for outcomes ≥6.5% vs ADA criteria. (Table 1) Tighter USPSTF screening parameters, however, missed identifying 36 patients with HbA1c 5.7%–6.4% and 6 with HbA1c ≥6.5%. Regardless of guidelines used, the post-hoc analysis shows that systematically screening patients is more effective than standard screening practices.

Limitations

While this investigation effectively articulated the frequency of diabetes screenings conducted under standard practice compared to a systematic approach and the outcomes of those screenings, it did not investigate what prompted or prevented the clinicians from screening patients. Future research should focus on (1) how to improve screening programs for chronic hyperglycemia, (2) methods to facilitate patients’ medical and personal behaviors to safely, effectively, and efficiently lower their glycemic curve, and (3) benefits of these screening and health initiatives on outcomes, including reductions in microvascular complications, economic cost impact, and change in quality of life.

Acknowledgements

Special thanks to the Diabetes Hands Foundation for funding the study and to Meg Sheppard, PhD, University of Alabama Institute for Rural Health Research for her support in developing the data collection form, and Larry Skelton, MD for welcoming this project into his rural family medicine clinic in Moundville, Alabama. Thanks to the Auburn University Institutional Review Board whom reviewed this protocol and approved it as expedited.

Footnotes

  • Conflicts of interest: authors report none.

  • Funding support: This project was funded through the Diabetes Hands Foundation through the Big Blue Test.

  • Prior presentations: Whitley HP, Hanson C. Improving the diagnostic rate of diabetes and prediabetes in an underserved rural clinic using a structured screening method and point-of-care A1C device. Presented at the American Diabetes Association 29th Annual Clinical Conference on Diabetes; May 22–25, 2014; Marco Island, Florida.

  • Supplementary materials: Available at http://www.AnnFamMed.org/content/15/2/162/suppl/DC1/

  • Received for publication April 26, 2016.
  • Revision received October 4, 2016.
  • Accepted for publication October 16, 2016.
  • © 2017 Annals of Family Medicine, Inc.

References

  1. ↵
    American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care. 2016; 39(Suppl 1): S1–S112.
    OpenUrlFREE Full Text
  2. ↵
    1. Whitley HP,
    2. Hanson C,
    3. Parton JM
    . Improving the undiagnosed rate of diabetes mellitus using a point-of-care A1C device. J Diabetes Metab Disord Control. 2015; 2(1): 00025.
    OpenUrl
  3. ↵
    1. Simmons RK,
    2. Rahman M,
    3. Jakes RW,
    4. et al
    . Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. Diabetologia. 2011; 54(2): 312–319.
    OpenUrl
  4. ↵
    1. Bubner TK,
    2. Laurence CO,
    3. Gialamas A,
    4. et al
    . Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Med J Aust. 2009; 190(11): 624–626.
    OpenUrlPubMed
    1. Cagliero E,
    2. Levina EV,
    3. Nathan DM
    . Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999; 22(11): 1785–1789.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Ferenczi A,
    2. Reddy K,
    3. Lorber DL
    . Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract. 2001; 7(2): 85–88.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Siu AL
    ; U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. preventative services task force recommendation statement. Ann Intern Med. 2015;163(11):861–868.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 15 (2)
The Annals of Family Medicine: 15 (2)
Vol. 15, Issue 2
March/April 2017
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes
Heather P. Whitley, Courtney Hanson, Jason M. Parton
The Annals of Family Medicine Mar 2017, 15 (2) 162-164; DOI: 10.1370/afm.2035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes
Heather P. Whitley, Courtney Hanson, Jason M. Parton
The Annals of Family Medicine Mar 2017, 15 (2) 162-164; DOI: 10.1370/afm.2035
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Monitoring Prediabetes Screening in Two Primary Care Offices in Rural Appalachia: A Quality Improvement Process
  • Prediabetes Knowledge, Attitudes, and Practices at an Academic Family Medicine Practice
  • In This Issue: On-the-Ground Advances & High-Level Influences
  • Google Scholar

More in this TOC Section

  • Patients Typing Their Own Visit Agendas Into an Electronic Medical Record: Pilot in a Safety-Net Clinic
  • Patient Attitudes and Participation in Hand Co-Washing in an Outpatient Clinic Before and After a Prompt
Show more Original Brief

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
    • Prevention
  • Person groups:
    • Older adults
  • Methods:
    • Quantitative methods
  • Other research types:
    • Professional practice

Keywords

  • diabetes
  • prediabetes
  • screening
  • hemoglobin A1C; HbA1c

Content

  • Current Issue
  • Past Issues
  • Past Issues in Brief
  • Multimedia
  • Articles by Type
  • Articles by Subject
  • Multimedia
  • Supplements
  • Online First
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Media
  • Job Seekers

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2023 Annals of Family Medicine